Cancer vaccines are showing promise at last
Groundbreaking study showing fierce immune response to fight malignant brain tumor featured in The Economist.
Groundbreaking study showing fierce immune response to fight malignant brain tumor featured in The Economist.
Dr. Elias Sayour earns honor from UF Innovate | Tech Licensing for his work in brain cancer immunotherapy.
Dr. Elias Sayour was featured for UF Innovate’s Tech Tuesday, discussing his work to develop mRNA brain cancer vaccines.
UF-developed mRNA vaccine quickly reprogrammed the immune system to attack glioblastoma.
Vast collection of brain and tissue samples will aid in studies to advance understanding of neurodegenerative diseases.
Drs. Elias Sayour and Daniel Wesson appointed to new leadership roles.
Dr. Elias Sayour is a co-director of new program connecting early-career investigators with senior faculty for support.
Drs. Steven Munger and Elias Sayour among those recognized for Innovations of the Year.
Brain cancer researcher Dr. Elias Sayour lent his expertise on mRNA vaccines' role to prevent COVID-19 infection for a UF Health-produced animation.
CTSI launches $2 million pilot research fund for scientists with translational projects that can be rapidly mobilized.